- Home
- USFD vs NBIX Comparison
USFD vs NBIX Comparison
Compare USFD & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | USFD | NBIX |
|---|---|---|
| Founded | 2007 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Food Distributors | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.8B | 13.9B |
| IPO Year | 2016 | 1996 |
Fundamental Metrics
Financial Performance| Metric | USFD | NBIX |
|---|---|---|
| Price | $92.15 | $129.65 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 22 |
| Target Price | $103.64 | ★ $175.27 |
| AVG Volume (30 Days) | ★ 2.2M | 944.3K |
| Earning Date | 05-11-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 45.54 | 41.95 |
| EPS | 2.94 | ★ 4.67 |
| Revenue | ★ $39,424,000,000.00 | $161,626,000.00 |
| Revenue This Year | $7.64 | $22.85 |
| Revenue Next Year | $3.99 | $9.99 |
| P/E Ratio | $32.20 | ★ $27.79 |
| Revenue Growth | 4.08 | ★ 977.51 |
| 52 Week Low | $57.36 | $84.23 |
| 52 Week High | $102.13 | $160.18 |
Technical Indicators
Market Signals| Indicator | USFD | NBIX |
|---|---|---|
| Relative Strength Index (RSI) | 49.61 | 46.02 |
| Support Level | $75.17 | $128.03 |
| Resistance Level | $102.13 | $136.74 |
| Average True Range (ATR) | 2.33 | 2.95 |
| MACD | -0.68 | 0.17 |
| Stochastic Oscillator | 46.46 | 35.28 |
Price Performance
Historical ComparisonAbout USFD US Foods Holding Corp.
US Foods Holding Corp is the U.S. food service distributor that distributes food and nonfood products to the healthcare and hospitality industries, restaurants, and education, government facilities, and grocers. It has nearly 250,000 restaurants and foodservice operators with more than 70 locations that provide customers with food offering and a comprehensive suite of e-commerce, technology, and business solutions. The company operates in one business segment in which it markets, sells and distributes fresh, frozen and dry food and non-food products to foodservice customers throughout the U.S.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.